Invitae Corporation – NYSE:NVTA

Founder-led company
Financial Health
0
1
2
3
4
5
6
7
8
9

Invitae stock price monthly change

-92.60%
month

Invitae stock price quarterly change

-92.13%
quarter

Invitae stock price yearly change

-98.22%
year

Invitae key metrics

Market Cap
5.44M
Enterprise value
1.84B
P/E
-0.11
EV/Sales
3.56
EV/EBITDA
-0.62
Price/Sales
0.67
Price/Book
3.42
PEG ratio
N/A
EPS
-5.38
Revenue
481.58M
EBITDA
-331.86M
Income
-1.44B
Revenue Q/Q
-9.20%
Revenue Y/Y
-7.38%
Profit margin
-601.64%
Oper. margin
-138.34%
Gross margin
19.18%
EBIT margin
-138.34%
EBITDA margin
-68.91%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Invitae stock price history

Invitae stock forecast

Invitae financial statements

Invitae Corporation (NYSE:NVTA): Profit margin
Dec 2022 122.45M -99.81M -81.51%
Mar 2023 117.35M -192.18M -163.76%
Jun 2023 120.53M -206.51M -171.33%
Sep 2023 121.24M -942.10M -777.05%
Invitae Corporation (NYSE:NVTA): Analyst Estimates
2025 592.46M -413.38M -69.77%
  • Analysts Price target

  • Financials & Ratios estimates

Invitae Corporation (NYSE:NVTA): Debt to assets
Dec 2022 1954116000 1.85B 94.79%
Mar 2023 1691663000 1.72B 102.17%
Jun 2023 1523039000 1.72B 113.18%
Sep 2023 535115000 1.61B 302.46%
Invitae Corporation (NYSE:NVTA): Cash Flow
Dec 2022 -82.02M 121.89M 599K
Mar 2023 -34.39M 73.87M -135.76M
Jun 2023 -54.90M 116.06M 876K
Sep 2023 -66.89M 5.11M -3.38M

Invitae alternative data

Invitae Corporation (NYSE:NVTA): Employee count
Aug 2023 1,700
Sep 2023 1,700
Oct 2023 1,700
Nov 2023 1,700
Dec 2023 1,700
Jan 2024 1,700
Feb 2024 1,700
Mar 2024 1,700
Apr 2024 1,700
May 2024 1,700
Jun 2024 1,700
Jul 2024 1,700

Invitae other data

93.57% -1.70%
of NVTA is owned by hedge funds
197.37M -10.66M
shares is hold by hedge funds

Invitae Corporation (NYSE:NVTA): Insider trades (number of shares)
Period Buy Sel
Aug 2022 0 40783
Dec 2022 0 55979
Mar 2023 0 9728
May 2023 0 206847
Jun 2023 0 14165
Transaction Date Insider Security Shares Price per share Total value Source
Sale
NUSSBAUM ROBERT L officer: Chief Me.. Common Stock 7,086 $1.38 $9,757
Sale
BRIDA THOMAS officer: See Remarks
Common Stock 7,079 $1.38 $9,748
Sale
KNIGHT KENNETH D. director, officer.. Common Stock 45,432 $1.2 $54,473
Sale
KNIGHT KENNETH D. director, officer.. Common Stock 45,432 $1.2 $54,473
Sale
NUSSBAUM ROBERT L officer: Chief Me.. Common Stock 26,476 $1.2 $31,745
Sale
WEN YAFEI officer: Chief Financial Officer
Common Stock 86,904 $1.6 $138,699
Sale
WERNER ROBERT F. officer: Chief Ac.. Common Stock 21,559 $1.2 $25,849
Sale
BRIDA THOMAS officer: See Remarks
Common Stock 26,476 $1.2 $31,745
Sale
WEN YAFEI
Common Stock 2,625 $1.41 $3,701
Sale
NUSSBAUM ROBERT L Common Stock 2,625 $1.41 $3,701
Patent
Grant
Filling date: 13 Feb 2020 Issue date: 19 Jul 2022
Application
Filling date: 9 Jun 2021 Issue date: 24 Mar 2022
Application
Filling date: 17 May 2021 Issue date: 2 Sep 2021
Application
Filling date: 29 Mar 2021 Issue date: 29 Jul 2021
Insider Compensation
Dr. Sean Emerson George Ph.D. (1974) Co-Founder, Pres, Chief Executive Officer & Director $451,350
Mr. Kenneth D. Knight (1961) Chief Operating Officer $428,500
Mr. Lee Bendekgey (1958) Chief Policy Officer
$383,640
Monday, 5 August 2024
prnewswire.com
Thursday, 1 August 2024
prnewswire.com
Monday, 22 July 2024
prnewswire.com
Wednesday, 24 April 2024
Reuters
Tuesday, 13 February 2024
Reuters
Tuesday, 6 February 2024
InvestorPlace
Monday, 5 February 2024
InvestorPlace
Reuters
Monday, 29 January 2024
The Motley Fool
Friday, 22 December 2023
Zacks Investment Research
Zacks Investment Research
Friday, 15 December 2023
InvestorPlace
Wednesday, 13 December 2023
Zacks Investment Research
Monday, 11 December 2023
InvestorPlace
Tuesday, 5 December 2023
The Motley Fool
Wednesday, 8 November 2023
Seeking Alpha
Zacks Investment Research
Saturday, 4 November 2023
The Motley Fool
Wednesday, 1 November 2023
The Motley Fool
Tuesday, 31 October 2023
InvestorPlace
Tuesday, 10 October 2023
PRNewsWire
Monday, 2 October 2023
The Motley Fool
InvestorPlace
Thursday, 21 September 2023
The Motley Fool
Thursday, 14 September 2023
The Motley Fool
Wednesday, 30 August 2023
The Motley Fool
Thursday, 24 August 2023
The Motley Fool
Friday, 11 August 2023
The Motley Fool
Friday, 28 July 2023
PennyStocks
Wednesday, 26 July 2023
The Motley Fool
  • When is Invitae's next earnings date?

    Unfortunately, Invitae's (NVTA) next earnings date is currently unknown.

  • Does Invitae pay dividends?

    No, Invitae does not pay dividends.

  • How much money does Invitae make?

    Invitae has a market capitalization of 5.44M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 12.13% to 516.3M US dollars.

  • What is Invitae's stock symbol?

    Invitae Corporation is traded on the NYSE under the ticker symbol "NVTA".

  • What is Invitae's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Invitae?

    Shares of Invitae can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Invitae's key executives?

    Invitae's management team includes the following people:

    • Dr. Sean Emerson George Ph.D. Co-Founder, Pres, Chief Executive Officer & Director(age: 51, pay: $451,350)
    • Mr. Kenneth D. Knight Chief Operating Officer(age: 64, pay: $428,500)
    • Mr. Lee Bendekgey Chief Policy Officer(age: 67, pay: $383,640)
  • Is Invitae founder-led company?

    Yes, Invitae is a company led by its founder Dr. Sean Emerson George Ph.D..

  • How many employees does Invitae have?

    As Jul 2024, Invitae employs 1,700 workers.

  • When Invitae went public?

    Invitae Corporation is publicly traded company for more then 10 years since IPO on 12 Feb 2015.

  • What is Invitae's official website?

    The official website for Invitae is invitae.com.

  • Where are Invitae's headquarters?

    Invitae is headquartered at 1400 16th Street, San Francisco, CA.

  • How can i contact Invitae?

    Invitae's mailing address is 1400 16th Street, San Francisco, CA and company can be reached via phone at +41 53747782.

Invitae company profile:

Invitae Corporation

invitae.com
Exchange:

NYSE

Full time employees:

1,700

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

1400 16th Street
San Francisco, CA 94103

CIK: 0001501134
ISIN: US46185L1035
CUSIP: 46185L103